Quagen Pharmaceuticals - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Representative image: A modern United States pharmaceutical production line illustrates Aurobindo Pharma Limited’s planned $250 million Lannett acquisition, which is set to expand its US generics manufacturing footprint after Federal Trade Commission clearance.

Read More

Pharma Industry News

Aurobindo Pharma clears FTC hurdle for $250m Lannett acquisition

Aurobindo Pharma clears the FTC hurdle for its $250 million Lannett deal. Explore divestitures, US expansion, integration risks and stock outlook.

June 19, 2026

web analytics